|
|
| (13 intermediate revisions by the same user not shown) |
| Line 2: |
Line 2: |
| | number = ML17121A356 | | | number = ML17121A356 |
| | issue date = 05/22/2017 | | | issue date = 05/22/2017 |
| | title = Final Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application and Response to Comments on the Draft Environmental Impact Statement (CAC No. MF6135) | | | title = Final Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application and Response to Comments on the Draft Environmental Impact Statement |
| | author name = Rikhoff J J | | | author name = Rikhoff J |
| | author affiliation = NRC/NRR/DLR/RERP | | | author affiliation = NRC/NRR/DLR/RERP |
| | addressee name = Lata T | | | addressee name = Lata T |
| Line 9: |
Line 9: |
| | docket = 05000609 | | | docket = 05000609 |
| | license number = | | | license number = |
| | contact person = Rikhoff J J, NRR-DLR 415-1090 | | | contact person = Rikhoff J, NRR-DLR 415-1090 |
| | case reference number = CAC MF6135 | | | case reference number = CAC MF6135 |
| | package number = ML17096A182 | | | package number = ML17096A182 |
| Line 15: |
Line 15: |
| | page count = 2 | | | page count = 2 |
| | project = CAC:MF6135 | | | project = CAC:MF6135 |
| | | stage = Draft Other |
| }} | | }} |
|
| |
|
| =Text= | | =Text= |
| {{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 May 22, 2017 | | {{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 May 22, 2017 Mr. Thomas Lata Vice President Osage Group of the Sierra Club 6901 W. Charlene Columbia, Missouri 65202 |
|
| |
|
| Mr. Thomas Lata Vice President Osage Group of the Sierra Club 6901 W. Charlene Columbia, Missouri 65202
| | ==SUBJECT:== |
| | FINAL ENVIRONMENTAL IMPACT STATEMENT FOR THE NORTHWEST MEDICAL ISOTOPES, LLC, MEDICAL RADIOISOTOPE PRODUCTION FACILITY CONSTRUCTION PERMIT APPLICATION AND RESPONSE TO COMMENTS ON THE DRAFT ENVIRONMENTAL IMPACT STATEMENT (CAC NO. MF6135) |
|
| |
|
| SUBJECT: FINAL ENVIRONMENTAL IMPACT STATEMENT FOR THE NORTHWEST MEDICAL ISOTOPES, LLC, MEDICAL RADIOISOTOPE PRODUCTION FACILITY CONSTRUCTION PERMIT APPLICATION AND RESPONSE TO COMMENTS ON THE DRAFT ENVIRONMENTAL IMPACT STATEMENT (CAC NO. MF6135) Dear Mr. Lata:
| | ==Dear Mr. Lata:== |
| The U.S. Nuclear Regulatory Commission (NRC) staff has completed the final environmental impact statement (EIS) for the Northwest Medical Isotopes, LLC, (NWMI) medical radioisotope production facility construction permit application. As requested, enclosed is a compact disc containing the final EIS. Responses to your comments are provided in Appendix A of the final EIS. If you have any questions regarding this matter, please contact Mr. David Drucker, Project Manager, for the environmental review of the NWMI construction permit application, by telephone at 301-415-6223 or by e-mail at david.drucker@nrc.gov. Sincerely,
| |
| /RA/ Jeffrey J. Rikhoff, Acting Chief Environmental Review and Project Management Branch Division of License Renewal Office of Nuclear Reactor Regulation Docket No. 50-609 Enclosure: Compact disk containing NWMI Final EIS
| |
|
| |
|
| T. Lata - 2 - SUBJECT: FINAL ENVIRONMENTAL IMPACT STATEMENT FOR THE NORTHWEST MEDICAL ISOTOPES, LLC, MEDICAL RADIOISOTOPE PRODUCTION FACILITY CONSTRUCTION PERMIT APPLICATION AND RESPONSE TO COMMENTS ON THE DRAFT ENVIRONMENTAL IMPACT STATEMENT (CAC NO. MF6135) | | The U.S. Nuclear Regulatory Commission (NRC) staff has completed the final environmental impact statement (EIS) for the Northwest Medical Isotopes, LLC, (NWMI) medical radioisotope production facility construction permit application. As requested, enclosed is a compact disc containing the final EIS. Responses to your comments are provided in Appendix A of the final EIS. |
| | If you have any questions regarding this matter, please contact Mr. David Drucker, Project Manager, for the environmental review of the NWMI construction permit application, by telephone at 301-415-6223 or by e-mail at david.drucker@nrc.gov. |
| | Sincerely, |
| | /RA/ |
| | Jeffrey J. Rikhoff, Acting Chief Environmental Review and Project Management Branch Division of License Renewal Office of Nuclear Reactor Regulation Docket No. 50-609 |
| | |
| | ==Enclosure:== |
| | Compact disk containing NWMI Final EIS |
| | |
| | T. Lata |
| | |
| | ==SUBJECT:== |
| | FINAL ENVIRONMENTAL IMPACT STATEMENT FOR THE NORTHWEST MEDICAL ISOTOPES, LLC, MEDICAL RADIOISOTOPE PRODUCTION FACILITY CONSTRUCTION PERMIT APPLICATION AND RESPONSE TO COMMENTS ON THE DRAFT ENVIRONMENTAL IMPACT STATEMENT (CAC NO. MF6135) |
| DISTRIBUTION: | | DISTRIBUTION: |
| HARD COPY: DLR RF E-MAIL: Public; RidsNrrDlr; RidsNrrDlrRerp; RidsNrrDpr; RidsNrrDprPrlb; RidsOgcMailCenter ------------------------------ AAdams, NRR DDrucker, NRR NMartinez, NRR MBalazik, NRR SLynch, NRR MMoser, NRR DTiktinsky, NMSS MYoung, OGC JWachutka, OGC VMitlyng, RIII PChandrathil, RIII ABarker, RIII HLogaras, RIII carolyn.haass@nwmedicalisotopes.com | | HARD COPY: |
| | | DLR RF E-MAIL: |
| ADAMS Accession Nos. ML17096A182 (PKG) ML17121A356 (LTR) | | Public; RidsNrrDlr; RidsNrrDlrRerp; RidsNrrDpr; RidsNrrDprPrlb; RidsOgcMailCenter AAdams, NRR DDrucker, NRR NMartinez, NRR MBalazik, NRR SLynch, NRR MMoser, NRR DTiktinsky, NMSS MYoung, OGC JWachutka, OGC VMitlyng, RIII PChandrathil, RIII ABarker, RIII HLogaras, RIII carolyn.haass@nwmedicalisotopes.com ADAMS Accession Nos. ML17096A182 (PKG) ML17121A356 (LTR) |
| ML17130A862 (Final EIS) | | ML17130A862 (Final EIS) |
| OFFICIAL RECORD OFFICE LA:DLR PM:RERP:DLR BC:RERP:DLR NAME YEdmonds DDrucker JRikhoff DATE 5/18/2017 5/18/2017 5/22/2017
| | OFFICE LA:DLR PM:RERP:DLR BC:RERP:DLR NAME YEdmonds DDrucker JRikhoff DATE 5/18/2017 5/18/2017 5/22/2017 OFFICIAL RECORD}} |
| }} | |
Letter Sequence Draft Other |
|---|
|
|
MONTHYEARML16292A7242016-11-0101 November 2016
Notice of Availability of the Draft Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application
Project stage: Draft Other
ML16294A4792016-11-0101 November 2016
Letter to Nicholas Fowler, Nwmi, Transmitting the Draft Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application
Project stage: Draft Other
ML16291A5132016-11-0303 November 2016
Nwmi Deis FRN - Notice of Availability and Public Meeting
Project stage: Request
ML16308A4342016-11-0707 November 2016
Notice of Availability of the Draft Environmental Impact Statement for the Northwest Medical Isotopes, Llc Radioisotope Production Facility Construction Permit Application (Cac No. MF6135)
Project stage: Draft Other
ML16364A2922016-12-0606 December 2016
Nwmi Deis Public Meeting Presentation Slides
Project stage: Request
ML16364A2812016-12-0606 December 2016
Nwmi Deis Public Meeting Transcript - December 6, 2016
Project stage: Request
ML17003A1492017-01-0303 January 2017
December 6, 2016 - Summary of Public Meeting Nwmi Deis
Project stage: Meeting
ML17121A3562017-05-22022 May 2017
Final Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application and Response to Comments on the Draft Environmental Impact Statement
Project stage: Draft Other
ML17114A2532017-05-22022 May 2017
Final EIS for Nwmi Construction Permit and Response to Comments on the Draft EIS from EPA
Project stage: Draft Other
ML17096A1832017-05-23023 May 2017
Notice of Availability of the Final Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application (CAC No. MF6135) to N. Fowler
Project stage: Other
ML17086A5822017-05-30030 May 2017
Letter from NRC to Nwmi Carolyn Haass Transmitting Nwmi Final EIS
Project stage: Other
ML17111A7252017-05-30030 May 2017
Maintenance of Reference Materials at the Daniel Boone Regional Library for the Environmental Review of Northwest Medical Isotopes, LLC Construction Permit Application
Project stage: Approval
2016-12-06
[Table View] |
|
|---|
Category:Letter
MONTHYEARML22147A1572022-07-11011 July 2022
Northwest Medical Isotopes, LLC - Termination of Construction Permit CPMIF-002
ML22084A0042022-02-0707 February 2022
Northwest Medical Isotopes, LLC (Nwmi), Request for Termination of Construction Permit No. CPMIF-002
ML19315A0132019-11-11011 November 2019
Northwest Medical Isotopes, LLC (Nwmi) Periodic Report Required by the License Conditions in Construction Permit No. CPMIF-002 (Docket No. 50-609), November 11, 2019
ML18163A0612018-11-16016 November 2018
Letter: Approval of Request for Exemption from Requirements of Title 10 of the Code of Federal Regulations, Paragraph 70.21 (F)
ML18318A3052018-11-0909 November 2018
Northwest Medical Isotopes, LLC (Nwmi) - Periodic Report Required by the License Conditions in Construction Permit No. CPMIF-002
ML18113A5042018-05-17017 May 2018
Letter to L. Tippet-Mosby Missouri Department of Natural Resources Request for Comments on North West Medical Isotopes Draft Environmental Assessment
ML18037A3082018-05-0909 May 2018
Northwest Medical Isotopes, LLC - Transmittal Letter Regarding Issuance of Construction Permit for a Medical Radioisotope Production Facility
ML18110A6072018-04-26026 April 2018
Acceptance for Review of Request for Exemption from Requirements of 10 CFR 70.21(F) for the Target Fabrication Portion of the Northwest Medical Isotopes Radioisotope Production Facility
ML18088A1752018-03-12012 March 2018
Supplemental Information Request - Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70.21(F), Filing, for Northwest Medical Isotopes, LLC Radioisotope Production Facility
ML17355A5292017-12-21021 December 2017
RIC Invitation Letter External Speaker 2018 Haass
ML17362A0402017-12-18018 December 2017
Northwest Medical Isotopes, LLC - Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70 21(F), Filing.
ML17353A0982017-12-18018 December 2017
Letter from Missouri Department of Natural Resources Regarding Northwest Medical Isotopes, LLC Application for Construction Permit
ML17349A1732017-12-14014 December 2017
Letter to Chairman Kristine Svinicki from Senators Ron Wyden and Claire Mccaskill Regarding Northwest Medical Isotopes, LLC Application for Construction Permit
ML17324A4122017-12-0808 December 2017
LTR-17-0431-1 - Report on Safety Aspects of the Construction Permit Application for Nwmi Medical Radioisotope Production Facility
ML17339A1972017-11-27027 November 2017
11-27-17 Ltr to Maurice Graham, Et Al., from Annette Vietti-Cook Notifying Him of That the Commission Is Convening an Evidentiary Hearing on the Construction Permit Application Associated with the Proposed Northwest Medical Isotopes Facilit
ML17332A6802017-11-24024 November 2017
11-24-17, Ltr to the Honorable Eric Greitens Et Al., Governor of Missouri from Denise Mcgovern Notifying Him of an Evidentiary Hearing for the Construction Permit Application Associated with Proposed Northwest Medical Isotopes Facility in C
ML17331B4452017-11-22022 November 2017
11-22-17 Letter to Bill Anoatubby Et Al, Governor, Chickasaw Nation from Annette Vietti-Cook Notifying Him of the Evidentiary Hearing for the Construction Permit Application Associated with the Proposed Northwest Medical Isotopes Facility i
ML17310A3662017-11-16016 November 2017
Transmittal Letter of Safety Evaluation Report for the Northwest Medical Isotopes, LLC, Constuction Permit Application
ML17310B5112017-11-0606 November 2017
Report on the Safety Aspects of the Construction Permit for Northwest Medical Isotopes, LLC, Radioisotope Production Facility
ML17283A1092017-09-28028 September 2017
Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit (TAC No. MF6138), Docket No. 50-609, Dated September 18, 2017
ML17283A1082017-09-28028 September 2017
Responses to Advisory Committee on Reactor Safeguards Questions on Docket No. 50-609, Northwest Medical Isotopes, LLC, NWMl-2013-021, Construction Permit Application for Radioisotope Production, at Meeting on September 21, 2017
ML17262A1112017-09-21021 September 2017
Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit
ML17265A0462017-09-19019 September 2017
Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit
ML17265A0482017-09-18018 September 2017
Responses to Advisory Committee on Reactor Safeguard Questions on Docket No. 50-609, Northwest Medical Isotopes, LLC, NWMI-2013-021, Construction Permit Application/Or Radioisotope Production, at Meetings on June 19, 2017; July 11, 2017; &
ML17268A3032017-09-15015 September 2017
Ltr from Missouri Dept of Natural Resources Dtd Sep 15, 2017, to Nwmi, Issuing 401 Water Quality Certification
ML17221A1992017-08-0707 August 2017
Transmittal of Revision 1 of Chapters 10.0, 11.0, 12.0 (Including Appendices 12A, 12b and 12C) and 14.0 and Revision 2 of Chapters 2.0, 3.0, 6.0, 7.0, 8.0 and 13.0 of NWMI-2013-021, Construction Permit Application for Radioisotope Productio
ML17193A4252017-07-0606 July 2017
Northwest Medical Isotopes, LLC - Transmittal of Revision 1 of Chapters 3.0, 6.0, 7.0, 8.0, 9.0, and 13.0 of NWMI-2013-021, Construction Permit Application for Radioisotope Production
ML17158B2672017-06-0303 June 2017
Northwest Medical Isotopes, LLC - Transmittal of Revision 1 of Chapters 1.0, 2.0, 4.0, and 5.0 of NWMl-2013-021, Construction Permit Application for Radioisotope Production Facility
ML17157B4112017-06-0202 June 2017
Northwest Medical Isotopes, LLC, Transmittal of Revision 2 of NWMI-2014-RPT-006, MCNP 6.1 Validations with Continuous Energy ENDF/B-VIL.1 Cross-Sections
ML17111A7252017-05-30030 May 2017
Maintenance of Reference Materials at the Daniel Boone Regional Library for the Environmental Review of Northwest Medical Isotopes, LLC Construction Permit Application
ML17086A5822017-05-30030 May 2017
Letter from NRC to Nwmi Carolyn Haass Transmitting Nwmi Final EIS
ML17132A3912017-05-24024 May 2017
Notice of Availability of the Final Environmental Impact Statement for the Proposed Northwest Medical Isotopes, LLC Radioisotope Production Facility Construction Permit
ML17096A1832017-05-23023 May 2017
Notice of Availability of the Final Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application (CAC No. MF6135) to N. Fowler
ML17114A2532017-05-22022 May 2017
Final EIS for Nwmi Construction Permit and Response to Comments on the Draft EIS from EPA
ML17121A3562017-05-22022 May 2017
Final Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application and Response to Comments on the Draft Environmental Impact Statement
ML17128A0652017-04-28028 April 2017
Northwest Medical Isotopes, LLC Responses to the NRC Environmental Request for Additional Information - Letter Dated January 25, 2017
ML17128A0662017-04-28028 April 2017
Northwest Medical Isotopes, LLC Response to the NRC Regarding the Request for Additional Information Regarding Application for Construction Permit (Letter Dated March 29, 2017)
ML17069A4082017-03-29029 March 2017
Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit
ML17061A1592017-03-22022 March 2017
Proprietary Determination Regarding Northwest Medical Isotopes Presentation November 10, 2016
ML17093A6612017-03-0606 March 2017
Northwest Medical Isotopes, LLC Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated January 25, 2017
ML17048A2712017-02-27027 February 2017
Northwest Medical Isotopes, LLC - Proprietary Determination Regarding Request for Information Responses Dated November 28, 2016
ML16344A0522016-11-28028 November 2016
Northwest Medical Isotopes, LLC - Responses to the U.S. Nuclear Regulatory Commission Regarding the Preliminary Safety Analysis Report Request for Additional Information
ML16305A2442016-11-10010 November 2016
Maintenance of Reference Materials at the Daniel Boone Regional Library for the Environmental Review of Northwest Medical Isotopes, Llc Construction Permit Application
ML16294A1352016-11-0707 November 2016
Notice of Availability of the Draft Environmental Impact Statement for the Construction Permit for the Proposed Northwest Medical Isotopes, LLC Radioisotope Production Facility
ML16293A8812016-11-0707 November 2016
Notice of Availability of the Draft Environmental Impact Statement for the Construction Permit for the Proposed Northwest Medical Isotopes, LLC Radioisotope Production Facility
ML16308A4342016-11-0707 November 2016
Notice of Availability of the Draft Environmental Impact Statement for the Northwest Medical Isotopes, Llc Radioisotope Production Facility Construction Permit Application (Cac No. MF6135)
ML16295A1292016-11-0404 November 2016
Notice of Availability of Nwmi DEIS-Tribal
ML16272A2942016-11-0101 November 2016
NRC to FWS Availability of the NWMI Draft EIS and Concurrence with ESA Determinations
ML16294A4792016-11-0101 November 2016
Letter to Nicholas Fowler, Nwmi, Transmitting the Draft Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application
ML16292A7242016-11-0101 November 2016
Notice of Availability of the Draft Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application
2022-07-11
[Table view] |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 May 22, 2017 Mr. Thomas Lata Vice President Osage Group of the Sierra Club 6901 W. Charlene Columbia, Missouri 65202
SUBJECT:
FINAL ENVIRONMENTAL IMPACT STATEMENT FOR THE NORTHWEST MEDICAL ISOTOPES, LLC, MEDICAL RADIOISOTOPE PRODUCTION FACILITY CONSTRUCTION PERMIT APPLICATION AND RESPONSE TO COMMENTS ON THE DRAFT ENVIRONMENTAL IMPACT STATEMENT (CAC NO. MF6135)
Dear Mr. Lata:
The U.S. Nuclear Regulatory Commission (NRC) staff has completed the final environmental impact statement (EIS) for the Northwest Medical Isotopes, LLC, (NWMI) medical radioisotope production facility construction permit application. As requested, enclosed is a compact disc containing the final EIS. Responses to your comments are provided in Appendix A of the final EIS.
If you have any questions regarding this matter, please contact Mr. David Drucker, Project Manager, for the environmental review of the NWMI construction permit application, by telephone at 301-415-6223 or by e-mail at david.drucker@nrc.gov.
Sincerely,
/RA/
Jeffrey J. Rikhoff, Acting Chief Environmental Review and Project Management Branch Division of License Renewal Office of Nuclear Reactor Regulation Docket No. 50-609
Enclosure:
Compact disk containing NWMI Final EIS
T. Lata
SUBJECT:
FINAL ENVIRONMENTAL IMPACT STATEMENT FOR THE NORTHWEST MEDICAL ISOTOPES, LLC, MEDICAL RADIOISOTOPE PRODUCTION FACILITY CONSTRUCTION PERMIT APPLICATION AND RESPONSE TO COMMENTS ON THE DRAFT ENVIRONMENTAL IMPACT STATEMENT (CAC NO. MF6135)
DISTRIBUTION:
HARD COPY:
DLR RF E-MAIL:
Public; RidsNrrDlr; RidsNrrDlrRerp; RidsNrrDpr; RidsNrrDprPrlb; RidsOgcMailCenter AAdams, NRR DDrucker, NRR NMartinez, NRR MBalazik, NRR SLynch, NRR MMoser, NRR DTiktinsky, NMSS MYoung, OGC JWachutka, OGC VMitlyng, RIII PChandrathil, RIII ABarker, RIII HLogaras, RIII carolyn.haass@nwmedicalisotopes.com ADAMS Accession Nos. ML17096A182 (PKG) ML17121A356 (LTR)
ML17130A862 (Final EIS)
OFFICE LA:DLR PM:RERP:DLR BC:RERP:DLR NAME YEdmonds DDrucker JRikhoff DATE 5/18/2017 5/18/2017 5/22/2017 OFFICIAL RECORD